The Partnership between the UAB Comprehensive Cancer Center (CCC), Tuskegee University (TU), and Morehouse School of Medicine (MSM) presents a unique opportunity to build on our successful accomplishments in training and education of the pipeline of future cancer research scientists, with emphasis on underrepresented racial/ethnic minorities. For this U54 application, The evaluation will be conducted by a team of evaluators representing each partnering institution, who meet monthly to discuss progress, issues, and solutions: Dr. Isabel Scarinci (UAB CCC), Dr. Desiree Rivers (MSM), and Mr. Lecarde Webb (TU). Although they will work together, each will be primarily responsible for specific Cores and Shared Resources. This team makes recommendations to be implemented administratively by the Principal Investigators with the advice, guidance, and direction of the Executive Committees (ECs) at each institution, the Partnership Leadership Committee (PLC), the Internal Advisory Committee, and the Program Steering Committee. These four committees also provide guidance to the PE Core members on adjustments to evaluation activities. Each Core and Shared Resource will have its own evaluation plan/worksheet outlining the evaluation questions for each specific aim, tasks, data collection tools, person responsible for each task, and timeline. The evaluator for each component will generate quarterly reports to be discussed with the ECs and the PLC. It should be noted that, although each component will have its own evaluation plan, an integrated evaluation process will be conducted to synergize all components to achieve the long-term outcomes.
The primary responsibility of the Planning and Evaluation (PE) Core is to evaluate the impact of research projects, cores, and shared resources of the Partnership in achieving its programmatic goal of eliminating cancer health disparities. Given the participatory and complex nature of the tripartite Partnership between MSM, TU, and the UAB CCC, we plan to implement, for the entire project, a participatory, mixed-method, triangulated, formal process, impact, and outcomes evaluation plan.
|Angajala, Anusha; Mothershed, Essynce; Davis, Melissa B et al. (2018) Quadruple Negative Breast Cancers (QNBC) Demonstrate Subtype Consistency among Primary and Recurrent or Metastatic Breast Cancer. Transl Oncol 12:493-501|
|Davis, Melissa; Tripathi, Shweta; Hughley, Raymond et al. (2018) AR negative triple negative or ""quadruple negative"" breast cancers in African American women have an enriched basal and immune signature. PLoS One 13:e0196909|
|Angajala, Anusha; Lim, Sangbin; Phillips, Joshua B et al. (2018) Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-Metabolism. Front Immunol 9:1605|
|Abisoye-Ogunniyan, Abisola; Lin, Huxian; Ghebremedhin, Anghesom et al. (2018) Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c. Cancer Lett 431:1-10|
|Mukherjee, Angana; Hollern, Daniel P; Williams, Oluwasina G et al. (2018) A Review of FOXI3 Regulation of Development and Possible Roles in Cancer Progression and Metastasis. Front Cell Dev Biol 6:69|
|Akintobi, Tabia Henry; Lockamy, Elise; Goodin, Lisa et al. (2018) Processes and Outcomes of a Community-Based Participatory Research-Driven Health Needs Assessment: A Tool for Moving Health Disparity Reporting to Evidence-Based Action. Prog Community Health Partnersh 12:139-147|
|Zhang, Wanguang; Zhang, Bixiang; Vu, Trung et al. (2017) Molecular characterization of pro-metastatic functions of ?4-integrin in colorectal cancer. Oncotarget 8:92333-92345|
|Yates, Clayton; Long, Mark D; Campbell, Moray J et al. (2017) miRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men. Front Biosci (Landmark Ed) 22:212-229|
|Piyathilake, Chandrika J; Badiga, Suguna; Borak, Samuel G et al. (2017) A higher degree of expression of DNA methyl transferase 1 in cervical cancer is associated with poor survival outcome. Int J Womens Health 9:413-420|
|Chen, Ina; Mathews-Greiner, Lesley; Li, Dandan et al. (2017) Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer. J Transl Med 15:92|
Showing the most recent 10 out of 141 publications